• 1. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 2. West China School of Medicine, Sichuan University, Chengdu, 610041, P.R.China;
  • 3. Evidence-based Medicine Center, Lanzhou University, Lanzhou, 730000, P.R.China;
TIAN Jinhui, Email: tjh996@163.com; DU Liang, Email: 125798620@qq.com
Export PDF Favorites Scan Get Citation

The PRISMA-DTA Statement is an expanded checklist of the original PRISMA, which is aimed at improving the reporting quality of the systematic review or meta-analysis of diagnostic test accuracy studies. It was published on JAMA in January 2018. This paper explained it and provided reference for improving the reporting quality of systematic review/meta-analysis of DTA for Chinese authors.

Citation: ZHANG Yonggang, YANG Letian, YANG Xin, XIAO Bowen, TIAN Jinhui, DU Liang. Interpretation and assessment of reporting guideline of systematic review/meta-analysis for diagnostic test accuracy study (PRISMA-DTA). Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 1007-1016. doi: 10.7507/1672-2531.201808012 Copy

  • Previous Article

    Interpretation of the Consolidated Standards of Reporting Trials (CONSORT) guideline for within person trials
  • Next Article

    Promoting data sharing in clinical trials to improve the transparency of clinical trials